ADVANCING BIOTECH ENTREPRENEURSHIP

CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects

ABOUT US

CEBINA was founded with the aim of creating, nurturing, and promoting early-stage life sciences companies, to develop new medicines and cutting-edge technologies.

  

With decades-long experience in pharmaceutical product development and biotech entrepreneurship, our team supports our internal projects and resident companies with cutting edge facilities and tailor-made services throughout all stages of company development.

  

For each new project, CEBINA undertakes extensive due diligence to identify projects with the highest potential, offering attractive, de-risked opportunities for investors.

4 May 2021

CEBINA reports potency of azelastine against emerging dominant variants of SARS-CoV-2 in laboratory testing

Read more

17 February 2021

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

Read more

19 November 2020

Eveliqure announces the publication of key preclinical data for its clinical stage vaccine candidate against Shigellosis and ETEC

Read more

CONTACT

Karl-Farkas-Gasse 22

1030 Vienna, Austria